BBOT News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-11 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-22 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.02,5.07. |
| 2026-05-12 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-04-29 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2026-04-23 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2026-03-26 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2026-03-05 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-01-07 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-11-12 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-08-13 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01. |
| 2025-08-06 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-08-04 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-07-11 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-03-03 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,9.01. |
| 2025-02-28 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-02-10 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-02-20 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-02-14 | Current report | SEC filing | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K | BridgeBio Oncology Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,5.02,5.03,8.01,9.01. |